EHA 2021 | Blinatumomab plus ponatinib for ALL update coming soon at EHA 2021

Name: Blinatumomab plus ponatinib for ALL update coming soon at EHA 2021
Uploaded: 2021-05-25T00:00:00Z
Duration: 22 s
Description: Nicholas Short, MD, MD Anderson Cancer Center, Houston, TX, discussess an update on blinatumomab plus ponatinib which will be presented at the virtual European Hematology Association (EHA) Congress 2021.

Nicholas Short • 25 May 2021

EHA 2021

Acute Myeloid Leukemia Leukemia Antibodies Blinatumomab Ponatinib

Nicholas Short, MD, MD Anderson Cancer Center, Houston, TX, discussess an update on blinatumomab plus ponatinib which will be presented at the virtual European Hematology Association (EHA) Congress 2021.

Disclosures

Nicholas Short, MD, has received consulting fees from Takeda Oncology and AstraZeneca; has received research funding from Takeda Oncology and Astellas Pharma Inc., and has received honoraria from Amgen.